Uscom Ltd (UCM) - Financial and Strategic SWOT Analysis Review

October 2021 | 45 pages | ID: U8713A3535AEN
GlobalData

Abstracts

Uscom Ltd (UCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Uscom Ltd (Uscom) is a medical device company which focuses on development, design, manufacture and marketing of non-invasive cardiovascular and pulmonary monitoring technologies. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac output monitor) non-invasive, beat to beat, real time cardiac output monitor based on continuous wave Doppler ultrasound; BP+, a non-invasive automatic blood pressure monitoring device based on supra systolic oscillometric central blood pressure technology and Spirosonic, an ultrasonic spirometer for pulmonary function testing. The company operates in China, Europe and the US. It markets products worldwide through distributors and partnerships. Uscom is headquartered in Sydney, Australia.

Uscom Ltd Key Recent Developments

Feb 24,2021: 4D half yearly report to 31 December 2020
Dec 09,2020: Uscom: H1 market update – FY 21 (5 mths) v FY 20 (6 mths)
Oct 15,2020: Uscom : 4C quarterly activities report to 30 September 2020
Feb 14,2020: New Hubei recommendations for children with Coronavirus support USCOM 1A use

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Uscom Ltd - Key Facts
Uscom Ltd - Key Employees
Uscom Ltd - Key Employee Biographies
Uscom Ltd - Major Products and Services
Uscom Ltd - History
Uscom Ltd - Company Statement
Uscom Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Uscom Ltd - Business Description
Product Category: Sales of Products
Performance
Product Category: Services Revenue
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Australia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other Regions
Performance
R&D Overview
Uscom Ltd - Corporate Strategy
Uscom Ltd - SWOT Analysis
SWOT Analysis - Overview
Uscom Ltd - Strengths
Uscom Ltd - Weaknesses
Uscom Ltd - Opportunities
Uscom Ltd - Threats
Uscom Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Uscom Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Uscom Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Uscom Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 24, 2021: 4D half yearly report to 31 December 2020
Dec 09, 2020: Uscom: H1 market update – FY 21 (5 mths) v FY 20 (6 mths)
Oct 15, 2020: Uscom : 4C quarterly activities report to 30 September 2020
Feb 14, 2020: New Hubei recommendations for children with Coronavirus support USCOM 1A use

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Uscom Ltd, Key Facts
Uscom Ltd, Key Employees
Uscom Ltd, Key Employee Biographies
Uscom Ltd, Major Products and Services
Uscom Ltd, History
Uscom Ltd, Subsidiaries
Uscom Ltd, Key Competitors
Uscom Ltd, Ratios based on current share price
Uscom Ltd, Annual Ratios
Uscom Ltd, Annual Ratios (Cont...1)
Uscom Ltd, Annual Ratios (Cont...2)
Uscom Ltd, Interim Ratios
Uscom Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Uscom Ltd, Medical Equipment, Deals By Type, 2015 to YTD 2021
Uscom Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Uscom Ltd, Performance Chart (2017 - 2021)
Uscom Ltd, Ratio Charts
Uscom Ltd, Medical Equipment, Deals By Year, 2015 to YTD 2021
Uscom Ltd, Medical Equipment, Deals by Type, 2015 to YTD 2021